company vector-laboratories 
Pharmaceutical Technology
FEBRUARY 15, 2023
In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Immuno-oncology in Pharmaceuticals: Gene therapy delivery using viral vectors. Sanofi is one of the leading patent filers working with viral vectors.
Pharma Leaders
JUNE 13, 2023
Charles River Laboratories International has teamed up with Korean biotechnology company Curigin for producing oncolytic ribonucleic acid interference (RNAi) gene therapy. The partnership will focus on the production of adenoviral vector. The company develops anticancer gene therapy products.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
DECEMBER 9, 2022
The site has been designed to be EMEA and FDA compliant, with Grade B and C suites to support high-throughput processes and accommodate bioreactor-scale cell therapy manufacturing in addition to on-site quality control (QC) laboratories and warehousing. Manufacturing facilities at the Gosselies campus . Catalent cell therapy manufacturing.
Pharmaceutical Technology
MAY 24, 2023
In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Recombinant viral vector-based medicinal preparations. Viral vectors are derived from different viruses and as such are characterised by different features.
Pharmaceutical Technology
MAY 8, 2023
Adeno-associated virus vectors, alcohol dehydrogenase compositions, and antibody serum stabilisers are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are anti-influenza antibody compositions and anti-interleukin-1, which are now well established in the industry.
European Pharmaceutical Review
AUGUST 22, 2022
Vaccines based on the two novel biotechnology platform-based techniques mRNA (messenger RNA) and viral vector, have proven successful in controlling the spread of the COVID-19 pandemic. By swapping the DNA strand embedded on the same vector (base platform carrier), a different vaccine can be generated, as illustrated in Figure 2.
Pharmaceutical Technology
MAY 8, 2023
Adeno-associated virus vectors, alcohol dehydrogenase compositions, and antibody serum stabilisers are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are anti-influenza antibody compositions and anti-interleukin-1, which are now well established in the industry.
Expert insights. Personalized for you.
98 
Let's personalize your content